Today's pre-market stock movers: PTON, PEP, NVAX, GPS and more
Gainers:
• $Canoo(GOEV.US$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Greenwich LifeSciences(GLSI.US$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed; suspends share repurchase program)
• $BELLUS Health(BLU.US$ +5.4% (reports End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough)
• $Cohu Inc(COHU.US$ +3.5% (Cohu (COHU) said Monday it expects Q2 revenue of $216 million to $218 million, higher than the guidance range mid-point of $213 million)
• $Leap Therapeutics(LPTX.US$ +3.2% (Leap Therapeutics and BeiGene (BGNE) announce the initiation of Part C of the ongoing DisTinGuish study to evaluate DKN-01 Leap's anti-SSEDickkopf 1 (DKK1) antibody in combination with tislelizumab BeiGene's anti-PD-1 antibody)
• $Peloton Interactive(PTON.US$ +2.6% (exits owned-manufacturing and expands partnership with Rexon)
• $Dave & Buster's Entertainment(PLAY.US$ +2.3% (names new execs following Main Event acquisition names new COO; entered into an amendment and restatement of the cooperation letter agreement with Hill Path Capital and James Chambers)
• PEP+1.3% (PepsiCo Inc. reported a 5.2% increase in revenue in the latest quarter, driven by price increases and strong sales of its snacks and packaged foods)
Analyst comments:
Losers:
• $RxSight(RXST.US$ -6.7% (received notification from the FDA that additional information will be required for the approval of its lower- cost-to-manufacture Light Delivery Device)
• $Gap Inc(GPS.US$ -6.1% (CEO will step down; names new CEO for Old Navy unit; reaffirms Q2 rev outlook but expects increased promotional activity)
• $Novavax(NVAX.US$ -2.2% (details modification to vaccine candidate for the SARS-CoV-2 virus contract)
Analyst comments:
• $Capital One Financial(COF.US$ -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley; downgraded to Perform from Outperform at Oppenheimer)
• $C.H. Robinson Worldwide(CHRW.US$ -1.5% (downgraded to Peer Perform from Outperform at Wolfe Research)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment